The decision to continue or discontinue should be made collaboratively between patient and clinician, weighing benefits against costs, side effects, and individual preferences, in accordance with current NICE guidance and local NHS commissioning arrangements
Temporary redness, swelling, and flaking are expected
LENS ai is not just accelerating developmentit's redefining the very process of therapeutic innovation." This approach positions LENS ai at the forefront of next-generation biologics, providing end-to-end in silico drug development capabilities with optimized safety and efficacy screening from the earliest stages of development, whether used by IPA or licensed to partners in the industry
Tambini says theres insufficient research supporting the use of Ozempic while breastfeeding
Please be aware that, in compliance with legal regulations, we are not authorized to provide dosing or reconstitution instructions